BioNTech: Κλείνει τρία εργοστάσια η εταιρεία που παρασκεύασε το εμβόλιο για την Covid-19
28 Articles
28 Articles
German biotechnology company BioNTech announced it will close production facilities in Germany and Singapore. The company, known for its Covid-19 vaccine, is shifting its resources to oncology and immunotherapy. The decision will affect 1,800 employees.
Biontech closes its plants in Marburg, Tübingen and Idar-Oberstein. Around 1,800 employees are affected.
BioNTech closes three sites and 1,800 jobs are affected. The Group will save heavily in the future and focus even more on cancer medicine.
The Mainz-based company "Biontech" closes three production sites in Germany. The plants in Marburg, Idar-Oberstein and Tübingen are affected with around 1800 employees.
The pharmaceutical company BioNTech closes its plants in Marburg, Idar-Oberstein and Tübingen. According to the company, the planned sale of the sites failed.
Biontech wanted to find buyers for three German production sites. The search has not been successful – around 1,800 jobs are affected.
Coverage Details
Bias Distribution
- 43% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium














